Tempus AI joined forces with Yale New Haven Hospital and Memorial Sloan Kettering Cancer Center. Together, they launched the new digital pathology IMS Open-Source Consortium. This group wants to make open-source digital pathology platforms available to everyone globally.
YNHH and MSK are the founding academic institutions for this initiative. They will actively shape the strategic direction and overall governance of the project. To help jumpstart the work, Tempus is open-sourcing its Paige Image Management System. This rollout includes the FullFocus slide viewer and FullFolio case management tool. Medical institutions around the globe can use this technology as a clinical-grade baseline solution.
Razik Yousfi, SVP and GM of AI Products at Tempus, shared his excitement about the future.
“Pathology is entering a transformative new era. Advances in deep learning and AI foundation models are enabling digital pathology to generate powerful insights directly from whole slide images, from cancer detection to molecular profiling. As demand for diagnostic and biomarker testing continues to rise, digital pathology offers a unique opportunity to enhance patient care by optimizing tissue utilization, uncovering actionable biomarkers, and improving laboratory workflows. We are excited to collaborate with YNHH and MSK to help bring the full potential of digital pathology into clinical practice.”
Developing Standardized Medical Workflows
Shared software standards will help doctors collaborate easily. These tools also allow teams to run labs more efficiently.
Chen Liu, MD, PhD, Chief of Pathology at YNHH, stressed the value of open innovation.
“Digital pathology is transforming how we deliver diagnostics, advance translational research, and integrate AI into clinical care. We are excited to join the Tempus IMS Consortium as a founding member and collaborate with leading academic and industry partners to help build an open, scalable, and interoperable digital pathology ecosystem. Open innovation and shared standards will be essential to accelerating adoption, improving workflow efficiency, and enhancing patient care.”
Right now, the medical field lacks open-access tools for slide viewing and AI deployment. This open-source IMS initiative represents an important first step for clinical workflows.
Saad Nadeem, PhD, Associate Attending Computer Scientist at MSK, highlighted this critical technology gap.
“Digital pathology lacks open-source and open-access clinical-grade solutions for on-prem/cloud slide viewing, case management, and AI deployment. This open source IMS initiative is an important first step, providing opportunities for companies/institutions to develop, deploy, validate, monitor, and disseminate AI solutions with standardized workflows. Building on MSK’s longstanding commitment and leadership in digital pathology, we look forward to working with our IMS Consortium partners to democratize access to digital pathology worldwide.”
This open-source consortium operates completely independently from the commercial side of Tempus. The alliance expects to bring on more members over time. Tempus continues to use its large multimodal data libraries to advance precision medicine.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
